Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Nov 02 2022

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-nov-02-2022-7

Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 02-Nov-2022 titled Alembic Pharmaceuticals receives USFDA Final Approval for Mesalamine Extended-Release Capsules USP, 0.375 g.

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases